ACROBiosystems, a provider of tools and solutions used from discovery to the clinic, has announced a new corporate initiative to support ex vivo cell manufacturing and manufacturers of cell and gene therapies.   This initiative represents the company’s new mission of “overcoming challenges from discovery to the clinic with innovation”. Manufacturing operations are a critical component of translational medicine, transforming the small-scale needs in discovery into consistent, high-v...